153 related articles for article (PubMed ID: 25308751)
1. Nitric oxide plays a key role in the suppressive activity of tolerogenic dendritic cells.
Verinaud L; Issayama LK; Zanucoli F; de Carvalho AC; da Costa TA; Di Gangi R; Bonfanti AP; Ferreira IT; de Oliveira AL; Machado DR; Thomé R
Cell Mol Immunol; 2015 May; 12(3):384-6. PubMed ID: 25308751
[No Abstract] [Full Text] [Related]
2. Immune tolerance induced by intravenous transfer of immature dendritic cells via up-regulating numbers of suppressive IL-10(+) IFN-γ(+)-producing CD4(+) T cells.
Zhou F; Ciric B; Zhang GX; Rostami A
Immunol Res; 2013 May; 56(1):1-8. PubMed ID: 23292714
[TBL] [Abstract][Full Text] [Related]
3. Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance.
Zhou Y; Leng X; Luo S; Su Z; Luo X; Guo H; Mo C; Zou Q; Liu Y; Wang Y
J Immunol Res; 2016; 2016():5021537. PubMed ID: 28070525
[TBL] [Abstract][Full Text] [Related]
4. 1,25-dihydroxyvitamin D
Xie Z; Chen J; Zheng C; Wu J; Cheng Y; Zhu S; Lin C; Cao Q; Zhu J; Jin T
Immunology; 2017 Nov; 152(3):414-424. PubMed ID: 28617989
[TBL] [Abstract][Full Text] [Related]
5. LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4
Zhou F; Zhang GX; Rostami A
Immunol Res; 2017 Jun; 65(3):630-638. PubMed ID: 27942984
[TBL] [Abstract][Full Text] [Related]
6. An increase in tolerogenic dendritic cell and natural regulatory T cell numbers during experimental autoimmune encephalomyelitis in Rras-/- mice results in attenuated disease.
Ray A; Basu S; Miller NM; Chan AM; Dittel BN
J Immunol; 2014 Jun; 192(11):5109-17. PubMed ID: 24771856
[TBL] [Abstract][Full Text] [Related]
7. Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis.
Thomé R; Moraes AS; Bombeiro AL; Farias Ados S; Francelin C; da Costa TA; Di Gangi R; dos Santos LM; de Oliveira AL; Verinaud L
PLoS One; 2013; 8(6):e65913. PubMed ID: 23799062
[TBL] [Abstract][Full Text] [Related]
8. Transduced B cells: B is for 'beneficial'!
Scott DW
Eur J Immunol; 2011 Jun; 41(6):1528-30. PubMed ID: 21618505
[TBL] [Abstract][Full Text] [Related]
9. Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
Mari ER; Rasouli J; Ciric B; Moore JN; Conejo-Garcia JR; Rajasagi N; Zhang GX; Rabinovich GA; Rostami A
Eur J Immunol; 2016 Jul; 46(7):1783-96. PubMed ID: 27151444
[TBL] [Abstract][Full Text] [Related]
10. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW
J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928
[TBL] [Abstract][Full Text] [Related]
11. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
Front Immunol; 2018; 9():3119. PubMed ID: 30687323
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine-treated dendritic cells require STAT1 signaling for their tolerogenic activity.
Thome R; Bonfanti AP; Rasouli J; Mari ER; Zhang GX; Rostami A; Verinaud L
Eur J Immunol; 2018 Jul; 48(7):1228-1234. PubMed ID: 29572810
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cells.
Benkhoucha M; Molnarfi N; Dunand-Sauthier I; Merkler D; Schneiter G; Bruscoli S; Riccardi C; Tabata Y; Funakoshi H; Nakamura T; Reith W; Santiago-Raber ML; Lalive PH
J Immunol; 2014 Sep; 193(6):2743-52. PubMed ID: 25114100
[TBL] [Abstract][Full Text] [Related]
14. A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4
Wan X; Pei W; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
J Immunol; 2018 Aug; 201(4):1194-1210. PubMed ID: 29987163
[TBL] [Abstract][Full Text] [Related]
15. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
[TBL] [Abstract][Full Text] [Related]
16. T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.
O'Brien K; Gran B; Rostami A
Immunotherapy; 2010 Jan; 2(1):99-115. PubMed ID: 20231863
[TBL] [Abstract][Full Text] [Related]
17. Selective depletion of CD11c
Wang L; Li Z; Ciric B; Safavi F; Zhang GX; Rostami A
Eur J Immunol; 2016 Oct; 46(10):2454-2466. PubMed ID: 27338697
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with autologous dendritic cells: from experimental autoimmune encephalomyelitis to multiple sclerosis.
Link H; Huang YM; Masterman T; Xiao BG
J Neuroimmunol; 2001 Mar; 114(1-2):1-7. PubMed ID: 11240009
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells in experimental allergic encephalomyelitis and multiple sclerosis.
Link H; Huang YM; Xiao BG
J Neuroimmunol; 1999 Dec; 100(1-2):102-10. PubMed ID: 10695720
[TBL] [Abstract][Full Text] [Related]
20. Midkine inhibits inducible regulatory T cell differentiation by suppressing the development of tolerogenic dendritic cells.
Sonobe Y; Li H; Jin S; Kishida S; Kadomatsu K; Takeuchi H; Mizuno T; Suzumura A
J Immunol; 2012 Mar; 188(6):2602-11. PubMed ID: 22323540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
